Clinical Edge Journal Scan

Clinical Edge Journal Scan

High-dose total body irradiation followed by stem cell transplantation offers long-term survival in MCL

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

A complete assessment of TP53 aberrations recommended before initiating ibrutinib in CLL

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Grade 3B FL prognostically similar to grade 3A FL but distinct from DLBCL

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

No benefit of adding ibrutinib to chemoimmunotherapy in relapsed/refractory mature B-cell non-Hodgkin lymphoma

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Zanubrutinib elicits favorable long-term responses in relapsed or refractory CLL or SLL

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Chronic lymphocytic leukemia: A risk factor for poor outcomes in patients hospitalized with immune thrombocytopenia

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Long-term benefits of axicabtagene ciloleucel in refractory large B-cell lymphoma

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Venetoclax may bridge to immunotherapy in relapsed/refractory mantle cell lymphoma

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Brexucabtagene autoleucel shows promise in relapsed or refractory mantle cell lymphoma in routine practice

Publish date: March 23, 2023

• Read More

Clinical Edge Journal Scan

Commentary: New treatment strategies for diffuse large B-cell lymphoma, March 2023

Publish date: March 1, 2023

• Read More

Pages

• « first
• …
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• last »